tiprankstipranks
MaxCyte sees Q4 revenue $8.3M-$8.5M, consensus $7.67M
The Fly

MaxCyte sees Q4 revenue $8.3M-$8.5M, consensus $7.67M

Total cash, cash equivalents, and investments as of December 31, 2024, is expected to be approximately $190M, compared to initial guidance and updated guidance in December of $175M and $185M, respectively, and compared to December 31, 2023 total cash, cash equivalents, and investments of $211M.

Stay Ahead of the Market:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App